• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·TMO
Held by 3 Gurus
Share

Thermo Fisher Scientific Inc. Stocks

$ 473.72Last Updated 15.06.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

$ 174.42B

$ 473.72
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Somewhat favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Manager
Fund
Portfolio Weight (%)
Change
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Sign up, to see portfolios that hold this stock
Sign up, to see portfolios that hold this stock

Latest news

30.01.2026 16:03

Morning in New York: uncertainty provokes correction

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Thermo Fisher Scientific Inc. is a prominent global entity that delivers a comprehensive suite of scientific instrumentation, specialized diagnostic offerings, laboratory supplies, biopharmaceutical services, and life science solutions. Its operational footprint extends across North America, Europe, Asia-Pacific, and other international regions. The company's Life Sciences Solutions division furnishes essential reagents, sophisticated instruments, and various consumables vital for biological and medical research, the advancement and manufacture of drugs and vaccines, and the identification of infections and diseases. This segment, encompassing biosciences, genetic sciences, and bioproduction, serves a broad spectrum of clients including pharmaceutical and biotechnology firms, agricultural businesses, clinical facilities, healthcare providers, academic institutions, and government agencies. Through its Analytical Instruments segment, the company supplies cutting-edge instruments, complementary consumables, software, and services to diverse sectors. These include pharmaceutical and biotechnology companies, academic and government research centers, environmental organizations, various industrial clients, and clinical diagnostic laboratories. The Specialty Diagnostics unit offers an array of diagnostic tools, including liquid, pre-mixed, and freeze-dried immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and specialized equipment. This segment also develops, produces, and markets complete blood test systems for the clinical detection and ongoing management of allergies, asthma, and autoimmune disorders. Additionally, it provides dehydrated and prepared culture media, sample collection and transport systems, related instrumentation, consumables, and human leukocyte antigen (HLA) typing and testing crucial for organ transplantation, as well as other general healthcare items. The Laboratory Products and Biopharma Services segment provides an extensive range of laboratory supplies, manages distribution for research and safety products, and delivers pharmaceutical services, including support for clinical research. The company's vast portfolio of products and services is distributed through multiple avenues: a dedicated direct sales team, customer service professionals, e-commerce platforms, and a network of third-party distributors. These offerings are marketed under well-recognized brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Founded in 1956, Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of TMO is 616 and suggests 29.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.06.2026 22:02

"Not a 'meme stock'": Why does an analyst believe Nebius shares are overvalued by more than 50%?

16.06.2026 21:29

Cathie Wood's funds bought 3 million shares of SpaceX. This is one of ARK's biggest moves in years.

16.06.2026 20:51

Britain is investigating reports of gunfire from a Russian warship in the English Channel

16.06.2026 20:38

Recently pivoted to quantum computing, QTREX soars 70% on production milestone

16.06.2026 19:17

On the third day of trading, SpaceX surpassed Amazon and Microsoft in market capitalization

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026